These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6262942)

  • 1. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis.
    Cooper B
    Blood; 1979 Sep; 54(3):684-93. PubMed ID: 380688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M; Berciaud P; Burtin M; Dechavanne M
    Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of prostaglandin-activated platelet adenylate cyclase.
    Cooper B; Schafer AI; Puchalsky D; Handin RI
    Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMP.
    Jakubowski JA; Ardlie NG; Nestel PJ
    Prostaglandins Med; 1980 Dec; 5(6):457-67. PubMed ID: 6258183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin and prostaglandins E2, I2, and D2 on the fetal circulation.
    Sideris EB; Yokochi K; Van Helder T; Coceani F; Olley PM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():477-82. PubMed ID: 6221634
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of prostaglandins E1, E2, D2, F2 alpha and I2 on the canine airways and pulmonary vascular bed (author's transl)].
    Kitamura S; Ishihara Y; Sugiyama Y; Hsu LH
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Sep; 17(9):560-6. PubMed ID: 393881
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 16. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of prostaglandin I2 and prostaglandin E2 stimulation of the rat kidney adenylate cyclase-cyclic AMP systems.
    Herman CA; Zenser TV; Davis BB
    Biochim Biophys Acta; 1979 Feb; 582(3):496-503. PubMed ID: 217441
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some naturally occurring prostaglandins of the D-, E-, and I-type and synthetic analogues on adenylate cyclase of human fat cell ghosts.
    Kather H; Simon B
    Res Exp Med (Berl); 1979 Oct; 176(1):25-9. PubMed ID: 392663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.